Can you provide the average price target for CELLECTIS stock?
13 analysts have analysed ALCLS.PA and the average price target is 6.63 EUR. This implies a price increase of 110.48% is expected in the next year compared to the current price of 3.15.
EPA:ALCLS • FR0010425595
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CELLECTIS (ALCLS.PA).
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 25.725M -33.35% | 9.193M -64.26% | 49.217M 435.37% | 69.087M 40.37% | 63.747M -7.73% | 44.805M -29.71% | 82.398M 83.90% | 82.976M 0.70% | 186.82M 125.15% | 224.24M 20.03% | 296.41M 32.18% | |
| EBITDA YoY % growth | -71.231M 18.04% | -78.779M -10.60% | -39.708M 49.60% | -69.319M -74.57% | -113.3M -63.45% | -155.53M -37.27% | -183.463M -17.96% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -89.666M 13.35% | -97.302M -8.52% | -59.554M 38.79% | -67.621M -13.54% | -100.93M -49.26% | -178.19M -76.55% | -43.229M 75.74% | -32.625M 24.53% | 50.869M 255.92% | 87.024M 71.07% | 137.1M 57.54% | |
| Operating Margin | -348.56% | -1,058.44% | -121.00% | -97.88% | -158.33% | -397.70% | -52.46% | -39.32% | 27.23% | 38.81% | 46.25% | |
| EPS YoY % growth | -2.37 39.26% | -1.78 24.77% | -0.35 80.34% | -0.94 -167.21% | -1.18 -26.29% | -1.44 -21.66% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.26 -430.89% | -0.25 -41.63% | -0.28 -18.74% | -0.23 -2,400.30% | -0.24 10.51% | -0.24 5.45% | -0.49 -72.05% | 0.02 107.61% | 0.40 267.83% |
| Revenue Q2Q % growth | 12.813M -15.51% | 17.789M 47.88% | 11.361M -37.55% | 19.498M -47.54% | 35.72M 178.78% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -12.365M 41.12% | -13.937M 1.71% | -14.902M 37.30% | -10.251M -227.48% | -15.197M -22.90% | N/A | N/A | N/A | N/A |
All data in USD
13 analysts have analysed ALCLS.PA and the average price target is 6.63 EUR. This implies a price increase of 110.48% is expected in the next year compared to the current price of 3.15.
CELLECTIS (ALCLS.PA) will report earnings on 2026-03-19, after the market close.
The consensus EPS estimate for the next earnings of CELLECTIS (ALCLS.PA) is -0.26 EUR and the consensus revenue estimate is 12.81M EUR.
The expected long term growth rate for CELLECTIS (ALCLS.PA) is -0.03%.